Picard Medical ($PMI) Pump-and-Dump Promotion Scheme Case

• $PMI investors filed a claim against Picard Medical for allegedly misleading investors and failing to disclose material risks tied to suspected stock-price manipulation following its low-float IPO, including the true nature of trading activity in $PMI.

• After reports and investigations pointed to an illicit, social-media-driven stock promotion campaign and $PMI’s price abruptly reversed, $PMI fell ~70% from $13.68 on October 23, 2025 to $3.99 on October 24, 2025.

• $PMI investors can join this case to be notified about potential recovery.

Between September 2, 2025, and October 31, 2025, Picard Medical promoted its medical-device business and outlook, including its artificial heart product, in ways investors say supported confidence in the company.

Stockholders alleged that during this time, $PMI was artificially inflated by a coordinated social-media promotion campaign, and that defendants failed to disclose risks tied to the stock’s trading activity and vulnerability to manipulation.

On October 24, 2025, $PMI fell about 70%.

Based on these events, $PMI investors filed a claim against Picard Medical, Inc. and other defendants, alleging the company:

• It omitted material risks that $PMI’s low-float IPO structure made the stock especially vulnerable to manipulation through coordinated promotions;

• It failed to disclose and/or correct allegedly irregular trading conditions and alleged promotion-driven activity impacting $PMI during the class period;

• It misled investors about the integrity of $PMI’s market price, contributing to losses when the alleged truth emerged and the price collapsed.

Investors argue Picard misled the market about the risks surrounding $PMI’s trading environment and susceptibility to manipulation, causing losses when the alleged artificial inflation reversed.